WallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock

$64.89+0.23 (0.36%)
Updated Apr 13, 2021
GILD Price
$64.89
Fair Value Price
N/A
Market Cap
$81.34B
52 Week Low
$56.56
52 Week High
$85.79
P/E
648.9x
P/B
4.47x
P/S
2.97x
PEG
2.04x
Dividend Yield
4.19%
Revenue
$24.69B
Earnings
$123.00M
Gross Margin
81.5%
Operating Margin
10.88%
Profit Margin
0.5%
Debt to Equity
2.76
Operating Cash Flow
$8B
Beta
0.64
Next Earnings
Apr 28, 2021
Ex-Dividend
N/A
Next Dividend
N/A

GILD Overview

Zen Score

High
Medium
Low
42
Industry average

Reasons for this score

GILD ($64.89) is trading below its intrinsic value of $96.79, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
GILD is poor value based on its earnings relative to its share price (648.9x), compared to the US market average (19.9x)
Valuation
GILD is poor value based on its earnings relative to its share price (648.9x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

1 of 13

GILD News

Valuation

GILD fair value

Fair Value of GILD stock based on Discounted Cash Flow (DCF)
Price
$64.89
Fair Value
$69.44
Undervalued by
6.55%
GILD ($64.89) is trading below its intrinsic value of $96.79, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation

GILD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
648.9x
Industry
8.76x
Market
19.9x
GILD is poor value based on its earnings relative to its share price (648.9x), compared to the US market average (19.9x)
Valuation
GILD is poor value based on its earnings relative to its share price (648.9x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

GILD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.47x
Industry
5.12x
Market
-0.01x
GILD is good value based on its book value relative to its share price (4.47x), compared to the US market average (-0.01x)
Valuation
GILD is good value based on its book value relative to its share price (4.47x), compared to the US Drug Manufacturers - General industry average (5.12x)
Valuation

GILD price to earnings growth (PEG)

For valuing profitable companies with growth potential
GILD is poor value relative to its rate of earnings growth, measured by PEG ratio (2.04x)
Valuation

GILD's financial health

Profit margin

Revenue
$7.4B
Net Income
$1.6B
Profit Margin
20.9%
GILD's Earnings (EBIT) of $2.69B are insufficient to safely cover interest payments on company debt ($31.40B)
Financials
GILD's profit margin has decreased (-23.5%) in the last year from (24%) to (0.5%)
Financials

Assets to liabilities

Assets
$68.4B
Liabilities
$50.2B
Debt to equity
1.73
GILD's short-term assets ($16.00B) exceed its short-term liabilities ($11.40B)
Financials
GILD's long-term liabilities ($38.79B) exceed its short-term assets ($16.00B)
Financials
GILD's debt has increased relative to shareholder equity (2.76), over the past 5 years ago (1.76)
Financials
GILD's debt to equity ratio (2.76) is considered high
Financials

Cash flow

Operating
$1.9B
Investing
-$9.0B
Financing
$131.0M
GILD's operating cash flow ($8.17B) is sufficient to service the company's debt ($31.40B)
Financials

Gilead Sciences Stock FAQ

What is Gilead Sciences's quote symbol?

(NASDAQ: GILD) Gilead Sciences trades on the NASDAQ under the ticker symbol GILD. Gilead Sciences stock quotes can also be displayed as NASDAQ: GILD.

What is the 52 week high and low for Gilead Sciences (NASDAQ: GILD)?

(NASDAQ: GILD) Gilead Sciences's 52-week high was $85.79, and its 52-week low was $56.56. It is currently -24.36% from its 52-week high and 14.73% from its 52-week low.

How much is Gilead Sciences stock worth today?

(NASDAQ: GILD) Gilead Sciences currently has 1,253,528,149 outstanding shares. With Gilead Sciences stock trading at $64.89 per share, the total value of Gilead Sciences stock (market capitalization) is $81.34B.

Gilead Sciences stock was originally listed at a price of $1.20 in Dec 31, 1997. If you had invested in Gilead Sciences stock at $1.20, your return over the last 23 years would have been 5,330.13%, for an annualized return of 18.97%.

How much is Gilead Sciences's stock price per share?

(NASDAQ: GILD) Gilead Sciences stock price per share is $64.89 today (as of Apr 13, 2021).

What is Gilead Sciences's Market Cap?

(NASDAQ: GILD) Gilead Sciences's market cap is $81.34B, as of Apr 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Gilead Sciences's market cap is calculated by multiplying GILD's current stock price of $64.89 by GILD's total outstanding shares of 1,253,528,149.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.